dc.contributor.author |
Xudayberganova Noila Xamitovna |
|
dc.date.accessioned |
2024-11-28T11:24:37Z |
|
dc.date.available |
2024-11-28T11:24:37Z |
|
dc.date.issued |
2024-09-03 |
|
dc.identifier.issn |
2938-3765 |
|
dc.identifier.uri |
http://repo.tma.uz/xmlui/handle/1/217 |
|
dc.description.abstract |
Fatty hepatosis is the most common chronic liver disease. According to statistics, non–alcoholic
fatty liver disease is found in 6.3-33% of adults worldwide. In obese patients, this figure is even
higher: it reaches 62-93%. The peak incidence in both men and women occurs at the age of 40-50
years. The mechanism of development of fatty hepatosis is quite complex and includes
environmental factors (nutrition and physical activity of a person), hormonal background, genetic
prerequisites. Normally, lipids should be transformed in the liver into other substances necessary
for the proper functioning of the digestive system. But instead, they penetrate into the hepatocytes
and accumulate there. The liver tissue in the areas of fatty infiltration becomes dense and can no
longer perform its tasks. Steatosis develops - the initial stage of non-alcoholic fatty liver disease |
en_US |
dc.language.iso |
en_US |
en_US |
dc.relation.ispartofseries |
Volume 2, Issue 8, August 2024; |
|
dc.subject |
fatty hepatosis, metabolic syndrome. |
en_US |
dc.title |
"THE CONCEPT OF FATTY LIVER DISEASE ASSOCIATED WITH METABOLIC SYNDROME" |
en_US |
dc.title.alternative |
Web of medicine, juornal of medicine, practice and nursing Volume 2, Issue 8, August 2024 ISSN (E): 2938-3765 |
en_US |
dc.type |
Article |
en_US |